Infant Bacterial Therapeutics AB (IFTBF) Q1 2026 Earnings

6FebConfirmed
Q4 2024
Q1 2025
Q4 2025
Q1 2026
-0.15
-0.13
-0.1
-0.08

Details

Expected EPS
N/A
Actual EPS
-0.154726
Surprise EPS
-0.15
Surprise Percent
+∞%

Description

Infant Bacterial Therapeutics AB (IFTBF) has reported earnings of -0.154726 per share for Q1 2026.

0 Comments

Share your thoughts